HIF1A and ovarian cancer: Therefore, the proliferation of ovarian cancer cells can be inhibited by silencing the activation of AMPK and suppressing the HIF-1α protein through transient receptor potential melastatin 7 (TRPM7), thereby adjusting the metabolic network and shifting the preferred glycolysis to oxidative phosphorylation (OXPHOS) (65, 66).